@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix go: . @prefix Protein: . @prefix mgi: . @prefix geneProductOf: . @prefix hasAgent: . @prefix do: . @prefix occursIn: . @prefix mesh: . @prefix hasAnnotation: . @prefix species: . @prefix obo: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasAgent: sub:_2; a go:0016301 . sub:_2 geneProductOf: mgi:97531; a Protein: . sub:_3 occursIn: do:162, mesh:D001808, obo:CL_0000669, species:10090; hasAnnotation: sub:_4; rdf:object sub:_1; rdf:predicate belv:directlyDecreases; rdf:subject schem:SU%206668; a rdf:Statement . sub:_4 dct:subject "TextLocation"; rdf:value "Abstract" . sub:assertion rdfs:label "a(SCHEM:\"SU 6668\") =| kin(p(MGI:Pdgfrb))" . } sub:provenance { beldoc: dce:description "Approximately 2000 hand curated statements drawn from 57 PubMeds."; dce:rights "Copyright (c) 2011-2012, Selventa. All Rights Reserved."; dce:title "BEL Framework Small Corpus Document"; dct:license "Creative Commons Attribution-Non-Commercial-ShareAlike 3.0 Unported License"; pav:authoredBy sub:_6; pav:version "20131211" . sub:_5 prov:value """targeting VEGFR-2 plus the platelet- derived growth factor receptor (PDGFR)-β system (PDGFR- β) signaling (by SU6668) rapidly forced 40% of tumor blood vessels into regression, rendering these tumors hypoxic as shown by phosphorescence quenching."""; prov:wasQuotedFrom pubmed:14657001 . sub:_6 rdfs:comment "support@belframework.org"; rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:14657001; prov:wasDerivedFrom beldoc:, sub:_5 . } sub:pubinfo { this: dct:created "2014-07-03T14:31:17.013+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }